Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicines
(1993; 94 pages)
Índice de contenido
Ver el documentoFOREWORD
Abrir esta carpeta y ver su contenido1. INTRODUCTION
Abrir esta carpeta y ver su contenido2. GENERAL CONSIDERATIONS IN HERBAL MEDICINE RESEARCH
Abrir esta carpeta y ver su contenido3. RESEARCH STUDIES
Cerrar esta carpeta4. USING THE GUIDELINES
Abrir esta carpeta y ver su contenidoA. GUIDELINES FOR QUALITY SPECIFICATIONS OF PLANT MATERIALS AND PREPARATIONS
Cerrar esta carpetaB. GUIDELINES FOR PHARMACODYNAMIC AND GENERAL PHARMACOLOGICAL STUDIES OF HERBAL MEDICINES
Ver el documentoANIMALS
Ver el documentoADMINISTRATION
Abrir esta carpeta y ver su contenidoC. GUIDELINES FOR TOXICITY INVESTIGATION OF HERBAL MEDICINES
Abrir esta carpeta y ver su contenidoANNEXES
Ver el documentoNOTES
Ver el documentoBIBLIOGRAPHY
Ver el documentoSELECTED WHO PUBLICATIONS OF RELATED INTEREST
 

ADMINISTRATION

Route of administration

Since oral dosage forms of herbal medicines are usually used clinically, the oral route of administration is ordinarily the most suitable for use with test animals. Additional routes may be used to approximate the intended route of administration in man.

Frequency of administration

Ordinarily, doses selected for a study should be established by means of a dose-response relationship but since such relationships often cannot be demonstrated with herbal medicines in whole animals, it may be sufficient to select one or more doses that provide a desired effect.

Selection of doses for animal studies should be in accordance with customary clinical doses.

Control group

It is essential that all studies include a negative (vehicle only) control group of animals and, if possible, a positive control group, that is, a group of animals in which the effect of a drug known to be positive is examined.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013